Results 1 to 10 of about 37,076 (119)

Hydroxy- and Amino-Phosphonates and -Bisphosphonates: Synthetic Methods and Their Biological Applications

open access: yesFrontiers in Chemistry, 2022
Phosphonates and bisphosphonates are stable analogs of phosphates and pyrophosphates that are characterized by one and two carbon–phosphorus bonds, respectively.
Babak Kaboudin   +3 more
doaj   +1 more source

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review

open access: yesJournal of Orthopaedic Translation, 2020
Objective: The objective of this study was to assess the efficacy and safety of denosumab therapy in osteoporotic postmenopausal women who were previously treated with bisphosphonates. Methods: Meta-analyses of four available randomised controlled trials
Yilin Zhu   +9 more
doaj   +1 more source

Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis

open access: yesTherapeutic Advances in Chronic Disease, 2022
Background: Bisphosphonates are a type of medication that prevents the loss of bone density. Secondary childhood osteoporosis reduces bone strength and results in an increased risk of fragility fracture.
Huawei Zhao   +5 more
doaj   +1 more source

Atypical femur fractures associated with chronic bisphosphonates use: A case series with 66 patients [PDF]

open access: yesRevista Brasileira de Ortopedia, 2022
Objective The present study aims to describe outcomes from a series of surgically treated patients with atypical femoral fracture due to bisphosphonates use, in addition to correlate the time of previous medication use with fracture consolidation time ...
Guilherme Guadagnini Falotico   +5 more
doaj   +1 more source

Assessment Results of Dental Students' Knowledge about Bisphosphonates and Bisphosphonate-Related Osteonecrosis of the Jaw

open access: yeseJournal of Oral Maxillofacial Research, 2023
Objectives: The aim of this cross-sectional study is to evaluate Lithuanian fourth- and fifth-year dental students' knowledge about bisphosphonates and bisphosphonate-related osteonecrosis of the jaw. Material and Methods: The anonymous survey using a
Greta Sereikaite   +4 more
doaj   +1 more source

Bisphosphonates Target B Cells to Enhance Humoral Immune Responses

open access: yesCell Reports, 2013
Bisphosphonates are a class of drugs that are widely used to inhibit loss of bone mass in patients. We show here that the administration of clinically relevant doses of bisphosphonates in mice increases antibody responses to live and inactive viruses ...
Elena Tonti   +14 more
doaj   +1 more source

Bisphosphonates

open access: yesTurkish Journal of Orthodontics, 2009
Bisphosphonates are used with the purpose of preventing bone resorption in some metabolic bone diseases. These drugs have been introduced into clinical use about 30 years ago and widely used in nowadays. As Orthodontic some different researches have been
Fırat Öztürk
doaj   +1 more source

Bisphosphonates and Atypical Hip Fractures: Current Status of Issue and Answers to Discussion Questions

open access: yesBolʹ, Sustavy, Pozvonočnik, 2012
The paper presents the recent data with the literature review on the controversial issue of the link between chronic administration of bisphosphonates, and atypical femoral shaft fractures.
I.Yu. Golovach
doaj   +1 more source

The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis

open access: yesTherapeutic Advances in Medical Oncology, 2019
Background: Adjuvant bisphosphonates reduce the rate of breast cancer recurrence in the bone and improve breast cancer survival. However, the risk of adverse events associated with bisphosphonate therapy for breast cancer remains poorly defined. Methods:
Yan-Li Yang   +4 more
doaj   +1 more source

Adherence to Bisphosphonates among People Admitted to an Orthopaedic and Geriatric Ward at a University Hospital in Sweden

open access: yesPharmacy, 2018
Oral bisphosphonates are the first choice of therapy to reduce the risk of osteoporotic fractures. These medications have generally poor oral bioavailability, which may further be reduced by concomitant intake of certain foods and drugs; therefore, it is
Linnea Abramsson, Maria Gustafsson
doaj   +1 more source

Home - About - Disclaimer - Privacy